© 2024 Blaze Media LLC. All rights reserved.
Pfizer, Allergan Call Off Proposed $160 Billion Merger After New Tax Rules Issued
April 06, 2016
The aggressive changes to U.S. tax laws announced this week helped to kill the deal.
NEW YORK (AP) — Allergan and Pfizer are calling off a record $160 billion merger after the Treasury issued new rules to make "tax inversions" less lucrative.
The aggressive changes to U.S. tax laws announced this week helped to kill the deal. The merger would have moved Pfizer's address — but not its operations or headquarters — to Ireland where it would pay far less in corporate taxes.
Pfizer Inc., based in New York, has agreed to pay Allergan PLC $150 million for reimbursement of expenses.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Sr. Editor, News
Dave Urbanski is a senior editor for Blaze News.
DaveVUrbanski
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.